Wealth Enhancement Advisory Services »

Pacira Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2026-06-30 $311k 12k 25.48
2025-12-31 $239k 9.5k 25.31
2025-09-30 $222k 9.4k 23.62
2025-06-30 $215k 9.3k 23.22

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Ishares Tr Core Us Aggbd Et (AGG)
NVIDIA Corporation (NVDA)
Alps Etf Tr Smith Core Plus (SMTH)
Microsoft Corporation Put Option (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Msci Intl Moment (IMTM)
Micron Technology (MU)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Pacira Pharmaceuticals

BlackRock
Doma Perpetual Capital Management
Vanguard Portfolio Management
Dimensional Fund Advisors
D. E. Shaw & Co
State Street Corporation
Renaissance Technologies
Vanguard Capital Management
Goldman Sachs Group
Morgan Stanley
Geode Capital Management
American Century Companies
UBS Group
Impax Asset Management Group
Two Sigma Investments

View all funds holding Pacira Pharmaceuticals